MedTrace Logo

Population Pharmacokinetics in Benznidazole-treated Adults With Chronic With Chagas Disease

NCT01755403 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2015-05-27

No results posted yet for this study

Summary

o study population pharmacokinetics in Benznidazole-treated adult patients with Chronic Chagas Disease to get information to optimize drug doses.

Conditions

  • Chagas Disease

Interventions

DRUG

Benznidazole

Sponsors & Collaborators

  • Barcelona Centre for International Health Research

    lead OTHER

Principal Investigators

  • Joaquim Gascón, PhD · Barcelona Centre for International Health Research (CRESIB)

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01755403 on ClinicalTrials.gov